ERBB2 and breast cancer: Pathologically, all cases were of the invasive ductal carcinoma (IDC) BC type with positive estrogen and progesterone receptor (ER and PR) status; 63.4% of the cases were HER-2 positive and 41.5% were premenopausal at the time of diagnosis.